Cargando…

Alternative and complementary therapies in osteoarthritis and cartilage repair

Osteoarthritis (OA) is the most common joint condition and, with a burgeoning ageing population, is due to increase in prevalence. Beyond conventional medical and surgical interventions, there are an increasing number of ‘alternative’ therapies. These alternative therapies may have a limited evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuggle, N. R., Cooper, C., Oreffo, R. O. C., Price, A. J., Kaux, J. F., Maheu, E., Cutolo, M., Honvo, G., Conaghan, P. G., Berenbaum, F., Branco, J., Brandi, M. L., Cortet, B., Veronese, N., Kurth, A. A., Matijevic, R., Roth, R., Pelletier, J. P., Martel-Pelletier, J., Vlaskovska, M., Thomas, T., Lems, W. F., Al-Daghri, N., Bruyère, O., Rizzoli, R., Kanis, J. A., Reginster, J. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170824/ https://www.ncbi.nlm.nih.gov/pubmed/32170710 http://dx.doi.org/10.1007/s40520-020-01515-1

Ejemplares similares

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
por: Fuggle, N. R., et al.
Publicado: (2020)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2013)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2014)

Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
por: Veronese, Nicola, et al.
Publicado: (2022)

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies
por: Veronese, Nicola, et al.
Publicado: (2022)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2018)

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2020)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2008)

Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
por: Honvo, Germain, et al.
Publicado: (2019)

Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
por: Bruyère, O., et al.
Publicado: (2011)

Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review
por: Beaudart, C., et al.
Publicado: (2017)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
por: Kanis, J. A., et al.
Publicado: (2017)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

Measures of attributes of locomotor capacity in older people: a systematic literature review following the COSMIN methodology
por: Honvo, Germain, et al.
Publicado: (2023)

Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial
por: Bruyère, Olivier, et al.
Publicado: (2021)

Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study
por: Bruyere, Olivier, et al.
Publicado: (2023)

Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Assessment and determinants of aesthetic discomfort in hand osteoarthritis
por: Neuprez, A, et al.
Publicado: (2015)

Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019)

Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
por: Bruyère, Olivier, et al.
Publicado: (2022)

Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J.A., et al.
Publicado: (2020)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J. A., et al.
Publicado: (2019)

Bone health assessment in older people with or without muscle health impairment
por: Locquet, M., et al.
Publicado: (2018)

Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report
por: Veronese, Nicola, et al.
Publicado: (2022)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
por: Chevalley, T., et al.
Publicado: (2021)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

SCOPE: a scorecard for osteoporosis in Europe
por: Kanis, J. A., et al.
Publicado: (2013)

Glucosamine sulphate: an umbrella review of health outcomes
por: Veronese, Nicola, et al.
Publicado: (2020)

Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Fuggle, Nicholas, et al.
Publicado: (2019)

Cost-effectiveness evaluation of glucosamine for osteoarthritis based on simulation of individual patient data obtained from aggregated data in published studies
por: Bruyère, Olivier, et al.
Publicado: (2019)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_luv09b1lo4kht7e1m65tfu01q7